September 25, 9:00 AM
Fulcrum Therapeutics (NASDAQ:FULC) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…
August 23, 2:31 PM
Tuesday, the FDA lifted the clinical hold on Fulcrum Therapeutics Inc's (NASDAQ: FULC) Investigational New Drug (IND) application for FTX-6058 for the potential treatment of
August 22, 3:07 PM
U.S. stocks traded mostly lower toward the end of trading, with the Dow Jones falling over 100 points on Tuesday. The Dow traded down 0.39% to 34,330.87 while the NASDAQ rose 0.24% to 13,530.50. The S&P 500, also fell, dropping, 0.11% to 4,394.78.
Why Macy’s Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session
August 22, 1:49 PM
Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) shares jumped 42.8% to $5.60 after the FDA lifted clinical hold on the company’s FTX-6058 for sickle cell disease.
August 22, 1:31 PM
Gainers Fulcrum Therapeutics (NASDAQ:FULC) stock rose 43.4% to $5.62 during Tuesday’s regular session. Fulcrum Therapeutics’s stock is trading…